BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: John G, Yildirim AO, Rubin BK, Gruenert DC, Henke MO. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. Am J Respir Cell Mol Biol 2010;42:424-31. [PMID: 19502387 DOI: 10.1165/rcmb.2008-0408OC] [Cited by in Crossref: 60] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dauletbaev N, Eklove D, Mawji N, Iskandar M, Di Marco S, Gallouzi IE, Lands LC. Down-regulation of cytokine-induced interleukin-8 requires inhibition of p38 mitogen-activated protein kinase (MAPK) via MAPK phosphatase 1-dependent and -independent mechanisms. J Biol Chem 2011;286:15998-6007. [PMID: 21454676 DOI: 10.1074/jbc.M110.205724] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
2 Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012;18:509-519. [PMID: 22481418 DOI: 10.1038/nm.2715] [Cited by in Crossref: 311] [Cited by in F6Publishing: 295] [Article Influence: 34.6] [Reference Citation Analysis]
3 Maniar-Hew K, Clay CC, Postlethwait EM, Evans MJ, Fontaine JH, Miller LA. Innate immune response to LPS in airway epithelium is dependent on chronological age and antecedent exposures. Am J Respir Cell Mol Biol 2013;49:710-20. [PMID: 23600597 DOI: 10.1165/rcmb.2012-0321OC] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
4 Yang J, Eiserich JP, Cross CE, Morrissey BM, Hammock BD. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic Biol Med. 2012;53:160-171. [PMID: 22580336 DOI: 10.1016/j.freeradbiomed.2012.05.001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 92] [Article Influence: 10.7] [Reference Citation Analysis]
5 Szul T, Bratcher PE, Fraser KB, Kong M, Tirouvanziam R, Ingersoll S, Sztul E, Rangarajan S, Blalock JE, Xu X, Gaggar A. Toll-Like Receptor 4 Engagement Mediates Prolyl Endopeptidase Release from Airway Epithelia via Exosomes. Am J Respir Cell Mol Biol 2016;54:359-69. [PMID: 26222144 DOI: 10.1165/rcmb.2015-0108OC] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
6 Cockx M, Gouwy M, Van Damme J, Struyf S. Chemoattractants and cytokines in primary ciliary dyskinesia and cystic fibrosis: key players in chronic respiratory diseases. Cell Mol Immunol 2018;15:312-23. [PMID: 29176750 DOI: 10.1038/cmi.2017.118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
7 Parker D, Prince A. Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol. 2011;45:189-201. [PMID: 21330463 DOI: 10.1165/rcmb.2011-0011rt] [Cited by in Crossref: 270] [Cited by in F6Publishing: 180] [Article Influence: 27.0] [Reference Citation Analysis]
8 Kim S, Beyer BA, Lewis C, Nadel JA. Normal CFTR inhibits epidermal growth factor receptor-dependent pro-inflammatory chemokine production in human airway epithelial cells. PLoS One 2013;8:e72981. [PMID: 23977375 DOI: 10.1371/journal.pone.0072981] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
9 Hampton TH, Ballok AE, Bomberger JM, Rutkowski MR, Barnaby R, Coutermarsh B, Conejo-Garcia JR, O'Toole GA, Stanton BA. Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells? Am J Physiol Lung Cell Mol Physiol 2012;303:L509-18. [PMID: 22821996 DOI: 10.1152/ajplung.00226.2011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chaudhary N, Marr KA. Impact of Aspergillus fumigatus in allergic airway diseases. Clin Transl Allergy. 2011;1:4. [PMID: 22410255 DOI: 10.1186/2045-7022-1-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
11 Parker D, Cohen TS, Alhede M, Harfenist BS, Martin FJ, Prince A. Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 2012;46:6-13. [PMID: 21778412 DOI: 10.1165/rcmb.2011-0080OC] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
12 Ito T, Schaller M, Raymond T, Joshi AD, Coelho AL, Frantz FG, Carson WF 4th, Hogaboam CM, Lukacs NW, Standiford TJ, Phan SH, Chensue SW, Kunkel SL. Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation. Am J Respir Crit Care Med 2009;180:1227-38. [PMID: 19797157 DOI: 10.1164/rccm.200906-0892OC] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
13 Maniar-Hew K, Postlethwait EM, Fanucchi MV, Ballinger CA, Evans MJ, Harkema JR, Carey SA, McDonald RJ, Bartolucci AA, Miller LA. Postnatal episodic ozone results in persistent attenuation of pulmonary and peripheral blood responses to LPS challenge. Am J Physiol Lung Cell Mol Physiol 2011;300:L462-71. [PMID: 21131396 DOI: 10.1152/ajplung.00254.2010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
14 Bruscia EM, Zhang PX, Satoh A, Caputo C, Medzhitov R, Shenoy A, Egan ME, Krause DS. Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis. J Immunol 2011;186:6990-8. [PMID: 21593379 DOI: 10.4049/jimmunol.1100396] [Cited by in Crossref: 92] [Cited by in F6Publishing: 90] [Article Influence: 9.2] [Reference Citation Analysis]
15 Entezari M, Weiss DJ, Sitapara R, Whittaker L, Wargo MJ, Li J, Wang H, Yang H, Sharma L, Phan BD. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis. Mol Med. 2012;18:477-485. [PMID: 22314397 DOI: 10.2119/molmed.2012.00024] [Cited by in Crossref: 59] [Cited by in F6Publishing: 68] [Article Influence: 6.6] [Reference Citation Analysis]
16 Chand HS, Mebratu YA, Montera M, Tesfaigzi Y. T cells suppress memory-dependent rapid mucous cell metaplasia in mouse airways. Respir Res 2016;17:132. [PMID: 27765038 DOI: 10.1186/s12931-016-0446-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Yonker LM, Cigana C, Hurley BP, Bragonzi A. Host-pathogen interplay in the respiratory environment of cystic fibrosis. J Cyst Fibros 2015;14:431-9. [PMID: 25800687 DOI: 10.1016/j.jcf.2015.02.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
18 Werner JL, Steele C. Innate receptors and cellular defense against pulmonary infections. J Immunol 2014;193:3842-50. [PMID: 25281754 DOI: 10.4049/jimmunol.1400978] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
19 Schögler A, Blank F, Brügger M, Beyeler S, Tschanz SA, Regamey N, Casaulta C, Geiser T, Alves MP. Characterization of pediatric cystic fibrosis airway epithelial cell cultures at the air-liquid interface obtained by non-invasive nasal cytology brush sampling. Respir Res 2017;18:215. [PMID: 29282053 DOI: 10.1186/s12931-017-0706-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
20 Wojewodka G, De Sanctis JB, Radzioch D. Ceramide in cystic fibrosis: a potential new target for therapeutic intervention. J Lipids 2011;2011:674968. [PMID: 21490807 DOI: 10.1155/2011/674968] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
21 Fiorotto R, Villani A, Kourtidis A, Scirpo R, Amenduni M, Geibel PJ, Cadamuro M, Spirli C, Anastasiadis PZ, Strazzabosco M. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity. Hepatology. 2016;64:2118-2134. [PMID: 27629435 DOI: 10.1002/hep.28817] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
22 Vencken SF, Greene CM. Toll-Like Receptors in Cystic Fibrosis: Impact of Dysfunctional microRNA on Innate Immune Responses in the Cystic Fibrosis Lung. J Innate Immun 2016;8:541-9. [PMID: 27043239 DOI: 10.1159/000444687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
23 Chaudhary N, Datta K, Askin FB, Staab JF, Marr KA. Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. Am J Respir Crit Care Med 2012;185:301-10. [PMID: 22135344 DOI: 10.1164/rccm.201106-1027OC] [Cited by in Crossref: 48] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
24 Li Y, Deshpande P, Hertzman RJ, Palubinsky AM, Gibson A, Phillips EJ. Genomic Risk Factors Driving Immune-Mediated Delayed Drug Hypersensitivity Reactions. Front Genet 2021;12:641905. [PMID: 33936169 DOI: 10.3389/fgene.2021.641905] [Reference Citation Analysis]
25 Wang R, Ahmed J, Wang G, Hassan I, Strulovici-Barel Y, Salit J, Mezey JG, Crystal RG. Airway epithelial expression of TLR5 is downregulated in healthy smokers and smokers with chronic obstructive pulmonary disease. J Immunol 2012;189:2217-25. [PMID: 22855713 DOI: 10.4049/jimmunol.1101895] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
26 Singh A, Ralhan A, Schwarz C, Hartl D, Hector A. Fungal Pathogens in CF Airways: Leave or Treat? Mycopathologia 2018;183:119-37. [PMID: 28770417 DOI: 10.1007/s11046-017-0184-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
27 Bannon A, Zhang SD, Schock BC, Ennis M. Cystic Fibrosis from Laboratory to Bedside: The Role of A20 in NF-κB-Mediated Inflammation. Med Princ Pract 2015;24:301-10. [PMID: 25925366 DOI: 10.1159/000381423] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
28 Belcher CN, Vij N. Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies. Curr Mol Med 2010;10:82-94. [PMID: 20205681 DOI: 10.2174/156652410791065408] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
29 Martinez-Anton A, Sokolowska M, Kern S, Davis AS, Alsaaty S, Taubenberger JK, Sun J, Cai R, Danner RL, Eberlein M, Logun C, Shelhamer JH. Changes in microRNA and mRNA expression with differentiation of human bronchial epithelial cells. Am J Respir Cell Mol Biol 2013;49:384-95. [PMID: 23590309 DOI: 10.1165/rcmb.2012-0368OC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
30 Kelly C, Canning P, Buchanan PJ, Williams MT, Brown V, Gruenert DC, Elborn JS, Ennis M, Schock BC. Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2013;304:L371-82. [PMID: 23316065 DOI: 10.1152/ajplung.00372.2011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
31 Comer DM, Elborn JS, Ennis M. Comparison of nasal and bronchial epithelial cells obtained from patients with COPD. PLoS One 2012;7:e32924. [PMID: 22412951 DOI: 10.1371/journal.pone.0032924] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
32 Kovach MA, Standiford TJ. Toll like receptors in diseases of the lung. Int Immunopharmacol 2011;11:1399-406. [PMID: 21624505 DOI: 10.1016/j.intimp.2011.05.013] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
33 Veit G, Bossard F, Goepp J, Verkman AS, Galietta LJ, Hanrahan JW, Lukacs GL. Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia. Mol Biol Cell. 2012;23:4188-4202. [PMID: 22973054 DOI: 10.1091/mbc.e12-06-0424] [Cited by in Crossref: 79] [Cited by in F6Publishing: 62] [Article Influence: 8.8] [Reference Citation Analysis]
34 Bertelsen A, Elborn SJ, Schock BC. Toll like Receptor signalling by Prevotella histicola activates alternative NF-κB signalling in Cystic Fibrosis bronchial epithelial cells compared to P. aeruginosa. PLoS One 2020;15:e0235803. [PMID: 33031374 DOI: 10.1371/journal.pone.0235803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Wang H, Cebotaru L, Lee HW, Yang Q, Pollard BS, Pollard HB, Guggino WB. CFTR Controls the Activity of NF-κB by Enhancing the Degradation of TRADD. Cell Physiol Biochem 2016;40:1063-78. [PMID: 27960153 DOI: 10.1159/000453162] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
36 Schnúr A, Hegyi P, Rousseau S, Lukacs GL, Veit G. Epithelial Anion Transport as Modulator of Chemokine Signaling. Mediators Inflamm 2016;2016:7596531. [PMID: 27382190 DOI: 10.1155/2016/7596531] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
37 Ralhan A, Laval J, Lelis F, Ballbach M, Grund C, Hector A, Hartl D. Current Concepts and Controversies in Innate Immunity of Cystic Fibrosis Lung Disease. J Innate Immun 2016;8:531-40. [PMID: 27362371 DOI: 10.1159/000446840] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]